Heinz-Josef Lenz, MD Professor of Medicine and Preventive Medicine Associate Director, Clinical Sciences J Terrence Lanni Chair in Cancer Research Director, USC Center for Molecular Pathways and Drug Discovery USC / Norris Comprehensive Cancer Center outlines an Update on Molecular Targeted Therapies for Metastatic colorectal cancers including in depth conversation on Next-generation sequencing, The Colorectal Cancer Subtyping Consortium, bevacizumab, EGFR, 80405 trial, Gerlinger et al., NEJM 2012, Circos plot illustrating genome-wide CNA, Liquid Biopsies, KRAS, MGH GI, RAS-WT CRC, ctDNA, CALGB, SWOG 80405, Cetuximab, FOLFIRI, FOLFOXIRI, CRICKET Trial, PD-1 Blockade, Nivolumab Monotherapy, BRAF, HER2 Overexpression,Trastuzumab,HER2, ZW25, DS-8201a, BEACON CRC Phase 3, PCM-075
Sponsors: